(Metallo)porphyrins as potent phototoxic anti-cancer agents after irradiation with red light

Autor: Pilar Ruiz-Sánchez, Urs Ziegler, Bernhard Spingler, Riccardo Rubbiani, Susmita Gupta, Gunnar Jeschke, Patchanita Thamyongkit, Anu Naik, Philipp M. Antoni, Pornkanok Munikorn, Gilles Gasser, Ina Albert, José María Mateos, Vera Luginbuehl
Přispěvatelé: University of Zurich, Spingler, Bernhard
Jazyk: angličtina
Rok vydání: 2014
Předmět:
10120 Department of Chemistry
Fluorescence guided surgery
Light
medicine.medical_treatment
Porphyrinoids
Photodynamic therapy
Photochemistry
01 natural sciences
law.invention
chemistry.chemical_compound
615: Pharmakologie und Therapeutik
law
Coordination Complexes
Neoplasms
540 Chemistry
polycyclic compounds
Electron paramagnetic resonance
Cytotoxicity
chemistry.chemical_classification
Photosensitizing Agents
Chemistry
3. Good health
540: Chemie
10024 Center for Microscopy and Image Analysis
Phototoxicity
EPR spectroscopy
Porphyrins
1503 Catalysis
Cell Survival
Radical
Antineoplastic Agents
010402 general chemistry
Catalysis
Porphyrine
Cell Line
Tumor

medicine
Humans
Reactive oxygen species
Spin trapping
010405 organic chemistry
Organic Chemistry
Electron Spin Resonance Spectroscopy
General Chemistry
Porphyrin
0104 chemical sciences
Photochemotherapy
Anticancer agents
Cisplatin
Reactive Oxygen Species
Copper
1605 Organic Chemistry
Popis: Novel photoactive (metallo)porphyrins were synthesised and characterised. When irradiated with light at a wavelength greater than 600 nm, these porphyrins act as photosensitisers and show high cytotoxicity towards two different human cancer cell lines with IC50 values down to 0.4 μM. A paramagnetic copper(II) porphyrin is the first photosensitiser to display excellent phototoxicity, explained by the electron paramagnetic resonance (EPR) spin trapping of hydroxy radicals and experimentally confirmed by the discovery of elevated levels of reactive oxygen species (ROS) inside A2780 cells after irradiation with red light. This finding indicates that paramagnetic compounds should be considered for photodynamic therapy (PDT). Furthermore, an additive effect of cisplatin and a zinc porphyrin, both at subtherapeutic concentrations of 0.22 μm, was observed.
Databáze: OpenAIRE